Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study
Anna Schaffner, Lorenz Risch, Myriam Weber, Sarah Thiel, Katharina Jüngert, Michael Pichler, Nadia Wohlwend, Thomas Lung, Michael Ritzler, Dorothea Hillmann, Sandra Copeland, Harald Renz, Matthias Paprotny, Martin Risch
Abstract
Article Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study was published on February 1, 2021 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 59, issue 2).
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakMedicineBetacoronavirusSars virusAntibodyPopulationCoronavirus InfectionsCoronavirusImmunologyOutbreakInternal medicineEnvironmental healthInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies